Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein

Guidelines for the welfare and use of animals in cancer research

Paul Workman, Eric O. Aboagye, Frances R. Balkwill et al. · British Journal of Cancer · 2010 · 1.4K citations · Full text

Medicine, Animal Sciences, Oncology +17

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

Giovanni Germano, Roberta Frapolli, Cristina Belgiovine et al. · Cancer Cell · 2013 · 862 citations · Full text

Life Sciences, Immunology, Oncology +14

Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells

Giovanni Germano, Roberta Frapolli, Matteo Simone et al. · Cancer Research · 2010 · 263 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors

A. Taamma, J. L. Misset, M. Riofrio et al. · Journal of Clinical Oncology · 2001 · 160 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Lurbinectedin Specifically Triggers the Degradation of Phosphorylated RNA Polymerase II and the Formation of DNA Breaks in Cancer Cells

Gema Santamaría Núñez, Carlos Mario Genes Robles, Christophe Giraudon et al. · Molecular Cancer Therapeutics · 2016 · 153 citations

Life Sciences, Molecular Biology, Oncology +17